Summary
World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.
Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.
Prudent Markets analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.
This research report indicated that the global Humira market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. In terms of the export, China occupied more than XX % export market share in 2019, India occupied XX %. XXX is the second largest region around the world, it occupied about XX % export market share in 2019. In terms of the Local Capacity, XXX is the largest region around the world, it occupied about XX % export market share in 2019.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Humira Market by Prudent Markets Include
China
EU
North America
Japan
India
Southeast Asia
South America
Middle East and Africa
Competitive Analysis; Who are the Major Players in Humira Market
Abbvie
Eisai
Cadila Healthcare
Torrent Pharmaceuticals
Amgen
Boehringer Ingelheim
...
Major Type of Humira Covered in Prudent Markets report:
Humira Syringe
Humira Pen
Application Segments Covered in Prudent Markets Market
Ankylosing Spondylitis
Rheumatoid Arthritis
Crohns Disease
Other
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Humira Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Humira Syringe -Product Introduction and Major Manufacturers
1.1.2 Humira Pen -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
2.1 China Humira Status and Prospect (2015-2026)
2.1.1 China Humira Market Size and Growth Rate (2015-2026)
2.1.2 China Humira Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.2 EU Humira Status and Prospect (2015-2026)
2.2.1 EU Humira Market Size and Growth Rate (2015-2026)
2.2.2 EU Humira Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.3 USA Humira Status and Prospect (2015-2026)
2.3.1 USA Humira Market Size and Growth Rate (2015-2026)
2.3.2 USA Humira Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.4 Japan Humira Status and Prospect (2015-2026)
2.4.1 Japan Humira Market Size and Growth Rate (2015-2026)
2.4.2 Japan Humira Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.5 India Humira Status and Prospect (2015-2026)
2.5.1 India Humira Market Size and Growth Rate (2015-2026)
2.5.2 India Humira Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.6 Southeast Asia Humira Status and Prospect (2015-2026)
2.6.1 Southeast Asia Humira Market Size and Growth Rate (2015-2026)
2.6.2 Southeast Asia Humira Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.7 South America Humira Status and Prospect (2015-2026)
2.7.1 South America Humira Market Size and Growth Rate (2015-2026)
2.7.2 South America Humira Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.8 Humira Status and Prospect (2015-2026)
2.8.1 Humira Market Size and Growth Rate (2015-2026)
2.8.2 Humira Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Humira Market Assessment by Segment
3.1 Global Humira Capacity and Growth Rate
3.2 Global Humira Sales by Type
3.3 Global Humira Sales Revenue by Type
3.4 Global Humira Consumption by Application
4 Global Humira Market Assessment by Regions
4.1 Global Humira Production Analysis and Forecast by Regions (2015-2026)
4.2 Global Humira Sales Analysis and Forecast by Regions (2015-2026)
4.3 Global Humira Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
5.1 Humira Value Chain Analysis
5.1.1 Upstream
5.1.2 Downstream
5.2 COVID-19 Impact on Humira Industry
5.2.1 Industrial Policy Issued Under the Epidemic Situation
5.3 Cost-Under the Epidemic Situation
5.3.1 Cost of Raw Material
5.4 Channel Analysis
5.4.1 Distribution Channel-Under the Epidemic Situation
5.4.2 Distributors
6 Competitive Landscape
6.1 Global Humira Capacity Market Share of Manufacturers (2019-2020)
6.2 Global Humira Sales Market Share of Manufacturers (2019-2020)
6.3 Global Humira Sales Revenue Market Share of Manufacturers (2019-2020)
7 Humira Competitive Analysis
7.1 Abbvie
7.1.1 Abbvie Company Profiles
7.1.2 Abbvie Product Introduction
7.1.3 Abbvie Humira Production, Revenue (2015-2020)
7.1.4 SWOT Analysis
7.2 Eisai
7.2.1 Eisai Company Profiles
7.2.2 Eisai Product Introduction
7.2.3 Eisai Humira Production, Revenue (2015-2020)
7.2.4 SWOT Analysis
7.3 Cadila Healthcare
7.3.1 Cadila Healthcare Company Profiles
7.3.2 Cadila Healthcare Product Introduction
7.3.3 Cadila Healthcare Humira Production, Revenue (2015-2020)
7.3.4 SWOT Analysis
7.4 Torrent Pharmaceuticals
7.4.1 Torrent Pharmaceuticals Company Profiles
7.4.2 Torrent Pharmaceuticals Product Introduction
7.4.3 Torrent Pharmaceuticals Humira Production, Revenue (2015-2020)
7.4.4 SWOT Analysis
7.5 Amgen
7.5.1 Amgen Company Profiles
7.5.2 Amgen Product Introduction
7.5.3 Amgen Humira Production, Revenue (2015-2020)
7.5.4 SWOT Analysis
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Company Profiles
7.6.2 Boehringer Ingelheim Product Introduction
7.6.3 Boehringer Ingelheim Humira Production, Revenue (2015-2020)
7.6.4 SWOT Analysis
8 Conclusion